4.4 Article

Changes in Brain-derived Neurotrophic Factor From Active and Sham Transcranial Direct Current Stimulation in Older Adults With Knee Osteoarthritis

期刊

CLINICAL JOURNAL OF PAIN
卷 37, 期 12, 页码 898-903

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/AJP.0000000000000987

关键词

transcranial direct current stimulation; knee osteoarthritis; brain-derived neurotrophic factor; BDNF

资金

  1. University of Florida Claude D. Pepper Older Americans Independence Center, Gainsville, FL [P30 AG028740]
  2. Isla Carroll Turner Endowment from The University of Texas Health Science Center at Houston, Houston, TX
  3. NIH/NINR, National Institute of Nursing Research, Bethesda, MD [R01NR019051]

向作者/读者索取更多资源

This study suggests that transcranial direct current stimulation (tDCS) could potentially reduce pain by decreasing brain-derived neurotrophic factor (BDNF) levels, and have effects on related neural circuits.
Objectives: Previous work has shown effects of transcranial direct current stimulation (tDCS) on clinical pain measures, qualitative sensory testing measures, and peripheral inflammation. The present report extends this research to investigate the effect of tDCS on brain-derived neurotrophic factor (BDNF) levels. Materials and Methods: This secondary analysis examined a sample of 40 older adults (50 to 70 y old) with symptomatic knee osteoarthritis randomly assigned in a 1:1 fashion to active (n=20) or sham (n=20) tDCS for 20 minutes on 5 consecutive days. BDNF was measured before the first session and after the final treatment session. Generalized linear modeling evaluated BDNF plasma levels as a function of tDCS group, adjusted for baseline. Bayesian statistical inference was used to quantify the probability that effects of the treatment exist. Results: Generalized linear modeling indicated a 90.4% posterior probability that the sham condition had 49.9% higher BDNF at the end of treatment, controlling for baseline. Follow-up analyses within the active TDCS group supported an association between change in BDNF and change in clinical pain, and exploratory analyses found an effect of tDCS on irisin. Discussion: Results indicated that tDCS could be a potential nonpharmacological treatment to decrease BDNF levels, which may in turn decrease pain. This study adds to a growing literature suggesting that tDCS affects cortical excitability, and consequentially, the neural circuits implicated in pain modulation. In addition to a direct connection to analgesia, BDNF changes may reflect tDCS-induced changes in different cortical areas and/or neural circuits.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据